Sign In
16 May 2019 14:06
16 May 2019
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Board Change
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, following the announcement on 11 March 2019 at the time of the Company's final results, announces that Professor Andrew Holmes, Non-Executive Director and Company Secretary, has stepped down from the Board with immediate effect.
The Board thanks Andrew for his dedication and support to the Company over the last 18 years. Bevan Metcalf, Finance Director, has taken on the additional responsibilities of Company Secretary.
Enquiries:
|
|
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD & Company Secretary | +44 (0) 1483 751 577 |
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson (Corporate Finance) Tom Salvesen (Corporate Broking)
|
+44 (0)20 7496 3000 |
IFC Advisory Ltd (Financial PR) Graham Herring Heather Armstrong Florence Chandler | +44 (0)20 3934 6630 |
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.
Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.
Follow the stocks
